Treatment selection in first-line metastatic renal cell carcinoma—the contemporary treatment paradigm in the age of combination therapy: a review
Importance The treatment landscape of metastatic renal cell carcinoma has evolved rapidly
over the last decade. Recent combination approaches heralded by targeting immune …
over the last decade. Recent combination approaches heralded by targeting immune …
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis
Abstract Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with
VEGFR-TKIs as first-line therapy significantly improve outcomes of metastatic renal cell …
VEGFR-TKIs as first-line therapy significantly improve outcomes of metastatic renal cell …
Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease
E Pan, D Urman, C Malvar… - Hematology/Oncology …, 2023 - hemonc.theclinics.com
This article focuses on favorable-risk metastatic renal cell carcinoma (mRCC) and its
management. Risk stratification of newly diagnosed mRCC is important for prognostication …
management. Risk stratification of newly diagnosed mRCC is important for prognostication …
Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis
Introduction Immunotherapy (IO)-based combination therapies have emerged as the
standard of care for first-line treatment of metastatic renal cell carcinoma (mRCC) among …
standard of care for first-line treatment of metastatic renal cell carcinoma (mRCC) among …
Prognostic Models in Metastatic Renal Cell Carcinoma
A Lemelin, K Takemura, DYC Heng… - Hematology …, 2023 - hemonc.theclinics.com
In the past decades, there have been important changes in the treatment landscape for
metastatic renal cell carcinoma (mRCC). With this evolution in therapies, the overall survival …
metastatic renal cell carcinoma (mRCC). With this evolution in therapies, the overall survival …
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database …
Background A novel prognostic model was recommended for patients with metastatic RCC
(mRCC) by the International mRCC Database Consortium (IMDC). In this study, we aimed to …
(mRCC) by the International mRCC Database Consortium (IMDC). In this study, we aimed to …
First-Line Systemic Treatment Options for Advanced Renal Cell Carcinoma
The treatment of advanced clear cell renal cell carcinoma (ccRCC) has undergone
significant changes over the last two decades, particularly with the development of …
significant changes over the last two decades, particularly with the development of …
Vascular endothelial growth factor Vascular endothelial growth factor receptor
R Proto-Oncogene - Integrating Multidisciplinary Treatment for …, 2023 - books.google.com
The 5-year survival rate for patients with localized kidney cancer has significantly increased
over the last decades; however, until recently, prognosis for patients with advanced disease …
over the last decades; however, until recently, prognosis for patients with advanced disease …